NovoCure (NASDAQ:NVCR) Earnings Information
NovoCure last posted its quarterly earnings data on February 25th, 2021. The medical equipment provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.09. The business earned $144 million during the quarter, compared to analyst estimates of $143.49 million. Its revenue was up 45.2% on a year-over-year basis. NovoCure has generated ($0.07) earnings per share over the last year and currently has a price-to-earnings ratio of 680.5. NovoCure has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 29th, 2021 based off prior year's report dates.
NovoCure Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
NovoCure (NASDAQ:NVCR) Earnings Estimates
2021 EPS Consensus Estimate: $0.48
2022 EPS Consensus Estimate: $0.88
NovoCure (NASDAQ NVCR) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)